Nortech Systems Incorporated 2012 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2012. The filing is an annual Form 10-K, not a standalone fourth-quarter filing. Nortech is a Minnesota-based electronic manufacturing services company serving aerospace and defense, medical, and industrial customers through facilities in the United States and Mexico.
Business Context
- Provides design support, prototyping, testing, supply-chain management, printed circuit board assemblies, wire and cable assemblies, medical devices, and higher-level electromechanical assemblies.
- Reports one operating segment: Contract Manufacturing within the EMS industry.
- The largest customer’s two divisions represented 24% of 2012 net sales, compared with 23% in 2011.
- Export sales represented 7% of 2012 net sales, compared with 6% in 2011.
- Headcount declined to 641 full-time and 76 part-time or temporary employees at year-end, from 710 full-time and 97 part-time or temporary employees in 2011.
Financial Performance and Liquidity
| Metric | 2012 | 2011 | Change |
|---|---|---|---|
| Net sales | $106.9 million | $114.2 million | Down 6% |
| Gross profit | $12.4 million | $13.3 million | Down 7% |
| Gross margin | 11.6% | 11.7% | Down 0.1 percentage point |
| Income from operations | $1.46 million | $1.51 million | Down 3% |
| Net income | $629,000 | $1.19 million | Down 47% |
| Diluted EPS | $0.23 | $0.43 | Down $0.20 |
| Cash from operating activities | $4.62 million | $(0.87) million | Improved $5.50 million |
| Working capital | $12.6 million | $12.3 million | Up $0.3 million |
- Sales declines occurred across all major markets: aerospace and defense declined 5% to $15.7 million, medical declined 3% to $32.5 million, and industrial declined 9% to $58.7 million.
- Operating expenses were $10.9 million, or 10.2% of sales, compared with $11.8 million, or 10.4%, in 2011. Selling expense increased to $4.3 million as the company invested in business development; general and administrative expense declined to $6.6 million after personnel redeployment and budget reductions.
- Other expense was $533,000 in 2012, primarily interest expense. In 2011, other income of $239,000 included a $791,615 bargain purchase gain from the Winland acquisition.
- Year-end cash was effectively zero. Accounts receivable declined to $13.6 million from $16.7 million, and inventory declined to $17.7 million from $19.0 million.
- Total assets were $44.5 million and shareholders’ equity was $21.1 million at December 31, 2012.
Cash Flow, Debt and Capital Resources
- Operating cash flow of $4.62 million was driven by earnings, depreciation, improved collections, and lower inventory spending.
- Investing cash flow was $(4.40) million, principally reflecting $4.43 million of property and equipment purchases, including the $2.65 million purchase of the Mankato building previously leased from Winland.
- Financing cash flow was $(226,000), including a $1.42 million reduction in the line of credit, $515,000 of long-term debt repayments, and $1.71 million of additional long-term borrowings.
- The Wells Fargo credit facility provided a $13.5 million line of credit, with $7.92 million outstanding at year-end and approximately $2.9 million of net unused availability based on the borrowing base.
- Long-term debt totaled $3.32 million, including $453,000 of current maturities. The company added a $1.7 million real estate term note in connection with the Mankato building purchase; the borrowing was funded on January 9, 2013.
- Management stated that financing arrangements and anticipated operating cash flows should satisfy working capital, capital expenditure, and debt repayment needs for the foreseeable future.
Material Changes and Unusual Items
- Revenue and net income declined materially because of weaker industrial demand and customer caution regarding inventory and forecasting.
- Medical backlog increased 24% to $7.0 million, while industrial backlog declined 17% to $7.5 million and aerospace and defense backlog declined 2% to $3.8 million.
- Total 90-day backlog was $18.3 million at year-end, broadly flat with $18.5 million in 2011.
- The 2011 results benefited from a $791,615 bargain purchase gain, which did not recur in 2012. Excluding the related after-tax gain, 2011 net income was approximately $0.7 million, or $0.24 per diluted share.
- The company recorded a $127,000 impairment charge on Fairmont, Minnesota assets held for sale, compared with $53,000 in 2011.
- The company terminated its 2007 FOCUS Incentive Plan in January 2012, cancelling 319,600 outstanding options.
- In February 2013, after year-end, the company granted 350,000 equity appreciation right units with redemption dates ranging from December 31, 2015 through December 31, 2019.
Outlook, Risks and Contingencies
- Management emphasized lean manufacturing, supply-chain initiatives, cost reduction, improved quality and delivery, customer diversification, and use of the Mexico operation for lower-cost production.
- No specific revenue, earnings, or margin guidance was provided.
- Key risks include economic weakness, competitive pricing pressure, customer concentration, order cancellations and rescheduling, excess or obsolete inventory, component shortages, labor availability, raw-material and energy costs, and execution problems.
- Mexico operations expose the company to political, economic, labor, transportation, weather, crime, and foreign-currency risks.
- Debt agreements contain financial, reporting, dividend, and capital expenditure covenants. The company reported compliance at December 31, 2012, but noncompliance could restrict borrowing or accelerate repayment.
- The company reported no material litigation and stated that its facilities were operating in compliance with applicable environmental laws. Environmental changes or remediation obligations could nevertheless create material costs.
- At December 31, 2012, unrecognized tax benefits were $140,000. No valuation allowance was recorded against deferred tax assets.
- Future minimum non-cancelable operating lease payments totaled approximately $588,000 through 2016, excluding other debt and contractual obligations.
Investor Verification Checklist
- Verify the borrowing-base calculation supporting approximately $2.9 million of unused credit availability and the terms and funding of the new Mankato real estate note.
- Assess whether industrial demand and customer concentration could pressure revenue, utilization, margins, and inventory reserves.
- Review the sustainability of the $4.62 million operating cash flow given lower earnings and the company’s lack of year-end cash.
- Reconcile reported net income with and without the nonrecurring 2011 bargain purchase gain.
- Review backlog quality, customer release timing, cancellation exposure, and the significant divergence between medical and industrial demand.
- Evaluate debt covenant headroom, variable-rate exposure, and scheduled maturities, including the additional amounts associated with the Mankato financing.
- Consider the potential cash obligations from equity appreciation rights, executive arrangements, warranties, taxes, leases, and environmental matters.
- Note that the auditor issued an unqualified opinion on the financial statements, but the company was not required to undergo—and the auditor did not provide—an opinion on the effectiveness of internal control over financial reporting.